ICP-723 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 2

Top Sponsors

Beijing InnoCare Pharma Tech Co., Ltd.2

Indications

Cancer2
Primary Central Nervous System Tumors Harboring NTRK Fusion1
Advanced Solid Tumors Harboring NTRK Fusion1
Solid Tumors1

Other2 trials

A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Phase 1/2

Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.